Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

GMHC Treatment Issues
Table of Contents, May, 1998

From Gay Men's Health Crisis

  • NTZ Set Back
    FDA Advisory Committee votes against approval of NTZ for cryptosporidiosis-related diarrhea

  • Heart Disease and HIV
    Protease inhibitors add extra risk due to their effect on raising lipid levels, but many other factors are at play

  • Treatment Briefs
    Efavirenz and Fortovase do not mix, Pharmacia & Upjohn seeks a buyer for its HIV drugs while Glaxo buys a new line of NNRTIs, Viagra and protease inhibitors, topical KS treatment goes to the FDA

  • PEP
    Prophylactic treatment following sexual exposure to HIV

    Advertisement

  • Just in Time for the World AIDS Conference
    Some tips on adjusting protease inhibitor regimens to other time zones

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by Gay Men's Health Crisis. It is a part of the publication GMHC Treatment Issues. Visit GMHC's website to find out more about their activities, publications and services.
 
 

Advertisement